One Rock Capital-backed Kensing completed the acquisition of Hopewell, VA amphoteric surfactants and specialty esters operations of Evonik.

One Rock Capital-backed Kensing, a manufacturer of natural vitamin E, plant sterols, specialty esters and high-purity anionic surfactants, completed the acquisition of the Hopewell, VA amphoteric surfactants and specialty esters operations of Evonik, a stock-listed German specialty chemicals company. Financial terms were not disclosed. "This transaction expands our existing surfactant and specialty esters product offerings and we're pleased to officially welcome our colleagues at the Hopewell site into the Kensing family. This transaction marks our second add-on acquisition since becoming a standalone company in June 2021. We look forward to building on this momentum by actively pursuing additional strategic opportunities aimed at providing our customers with an expanded range of high quality, plant-based products and strengthening our leading position in our core markets." Serge Rogasik, Kensing CEO.